| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 10778 |
| 1 | DEXAMETHASONE 1.5 MG | 10770 |
| 2 | LENALIDOMIDE | 6731 |
| 3 | CYCLOPHOSPHAMIDE | 6679 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 6679 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6679 |
| 6 | RITUXIMAB | 6117 |
| 7 | CARBOPLATIN | 6084 |
| 8 | PREDNISONE | 5793 |
| 9 | METHOTREXATE SODIUM | 5513 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBRITUMOMAB TIUXETAN | 174 | 0.1142 |
| 1 | PSYLLIUM HUSK | 151 | 0.1118 |
| 2 | TIROFIBAN | 312 | 0.1073 |
| 3 | SELINEXOR | 768 | 0.0876 |
| 4 | ONASEMNOGENE ABEPARVOVEC-XIOI | 201 | 0.0871 |
| 5 | TRABECTEDIN | 202 | 0.0860 |
| 6 | EPTIFIBATIDE | 65 | 0.0842 |
| 7 | TEDIZOLID PHOSPHATE | 62 | 0.0772 |
| 8 | MOMELOTINIB | 112 | 0.0756 |
| 9 | TEMOZOLOMIDE | 1592 | 0.0747 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 21105 |
| 1 | Platinum-based Drug [EPC] | 12823 |
| 2 | Alkylating Drug [EPC] | 10230 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 10230 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9934 |
| 5 | Thalidomide Analog [EPC] | 7763 |
| 6 | Kinase Inhibitor [EPC] | 6548 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 6297 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 5926 |
| 9 | Proton Pump Inhibitor [EPC] | 5686 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Platelet-derived Growth Factor [EPC] | 1 | 1.0000 |
| 1 | CD25-directed Cytotoxin [EPC] | 1 | 0.1000 |
| 2 | Nuclear Export Inhibitor [EPC] | 768 | 0.0876 |
| 3 | Oxazolidinone Antibacterial [EPC] | 2242 | 0.0741 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 1052 | 0.0693 |
| 5 | Lymphocyte Growth Factor [EPC] | 84 | 0.0665 |
| 6 | Histone Deacetylase Inhibitor [EPC] | 257 | 0.0663 |
| 7 | CD33-directed Immunoconjugate [EPC] | 240 | 0.0655 |
| 8 | CD123 Interaction [EPC] | 35 | 0.0651 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 332 | 0.0567 |